NCT02317705 2022-06-21Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian CancerOn Target Laboratories, LLCPhase 2 Completed48 enrolled 10 charts
NCT03180307 2022-02-04OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian CancerOn Target Laboratories, LLCPhase 3 Completed140 enrolled 11 charts 2 FDA
NCT02785731 2018-11-09Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.Angle plcCompleted204 enrolled